Unichem Q2 net profit rises 3.49% `23 cr
Total income from operations also rose to `305.55 cr on stand-alone basis in the September quarter compared with `278.15 cr a year ago17-10-2015
17-10-2015
Financial Results & Limited Review Report for Sept 30, 2015 (Standalone)
Unichem Laboratories Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015.17-10-2015
Unichem gets USFDA nod for hypertension treatment tablets
Drug firm Unichem Laboratories has received approval from the US health regulator for its Losartan Potassium tablets used in treatment of hypertension.16-10-2015
Unichem Laboratories receives ANDA approval from USFDA for Losartan Potassium Tablets USP
Unichem Laboratories Ltd has submitted to BSE a copy of Press Release dated October 16, 2015 titled "Unichem Laboratories receives ANDA approval from USFDA for Losartan Potassium Tablets USP".16-10-2015
Unichem gets USFDA nod to market Alzheimer treatment drug
Drug firm Unichem Laboratories has received US health regulators approval to market its Memantine Hydrochloride tablets USP, used to treat severe dementia of the Alzheimers type, in the American...14-10-2015
Unichem Laboratories receives Final ANDA approval from USFDA for Memantine Hydrochloride Tablets USP
Unichem Laboratories Ltd has submitted to BSE a copy of Press Release dated October 14, 2015 titled "Unichem Laboratories receives Final ANDA approval from USFDA for Memantine Hydrochloride Tablets USP".14-10-2015
Unichem Labs jumps on report of sale plans
Shares of Unichem Laboratories Ltd, a mid-sized Indian drugmaker, today jumped as much as 3 per cent to Rs 315.75. The drugmaker is exploring the sale of its domestic formulations busines...12-10-2015
Updates
Unichem Laboratories Ltd has informed BSE that there is a News article on October 12, 2015 mentioning that the Company plans sale of its Domestic Formulations business.The Company denies the same as it is a rumour.12-10-2015
Shareholding Pattern For September 30, 2015
Unichem Laboratories Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015.10-10-2015
Unichem Gets USFDA Nod for Generic Asthma Treatment Tablets
"The company has received ANDA approval for Motelukast Sodium tablets from the United States Food and Drug Administration (USFDA)," Unichem Laboratories said in a filing to BSE.09-10-2015